Mitra-9™ is a premium mitragynine-based tablet created for experienced kratom consumers seeking the closest legal alternative to 7-hydroxymitragynine (7-OH) in states where 7-OH products are restricted or unavailable.

Developed by Cloud, Mitra-9 delivers a consistent, modern kratom experience by focusing on mitragynine—the primary naturally occurring alkaloid in kratom leaf—without the inclusion of isolated or added 7-OH.

This makes Mitra-9 a future-proof, 100% compliant solution for retailers and consumers navigating an evolving regulatory landscape.

As regulations continue to tighten around 7-hydroxymitragynine, many users are searching for a legal kratom alternative that still aligns with their expectations for potency, reliability, and quality.

Mitra-9 was engineered specifically for that audience.

This approach allows Mitra-9 to occupy the space between traditional kratom powder and high-risk extract products, offering a balanced option that retailers can confidently stock.

Product Overview

Mitra-9™ contains mitragynine only and does not include added 7-hydroxymitragynine (7-OH). Each batch is produced with strict quality standards to ensure consistency, transparency, and regulatory alignment.

Retailers benefit from a high-interest product that avoids the legal uncertainty associated with 7-OH extracts.

Mitra-9 is intended for:

• Not intended for first-time kratom users.

Cloud is committed to responsible formulation and accurate labeling. Mitra-9™ is clearly categorized, properly labeled, and designed to meet modern retail expectations for compliance and consumer clarity.